Inventor · disambiguated record
George P. Luke
Also filed as: LUKE GEORGE · LUKE GEORGE P
29 granted patents·10 pending applications·360 citations·filing 1995–2025
97Inventor score
Top patents by PatentIndex Score
39 records- 0198US10532047B2Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrileFORMA THERAPEUTICS INC·Filed 2019·Granted Jan 14, 2020·12 cites·20 claims
- 0297US10336722B2Tetrahydroquinoline compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Jul 2, 2019·22 cites·47 claims
- 0397US9422281B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2014·Granted Aug 23, 2016·25 cites·35 claims
- 0496US11111229B2Tetrahydroquinoline compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2020·Granted Sep 7, 2021·4 cites·22 claims
- 0596US10377769B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·10 cites·28 claims
- 0696US9388161B2Tetrahydroquinoline compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2014·Granted Jul 12, 2016·34 cites·44 claims
- 0794US10611750B2Tetrahydroquinoline compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Apr 7, 2020·7 cites·38 claims
- 0892US7642267B2Benzimidazole and pyridylimidazole derivativesNEUROGEN CORP·Filed 2007·Granted Jan 5, 2010·20 cites·21 claims
- 0991US6949562B2Heterocyclic compounds as ligands of the GABAA receptorPFIZER·Filed 2003·Granted Sep 27, 2005·54 cites·34 claims
- 1091US6653471B2Heterocyclic compounds as ligands of the GABAA receptorNEUROGEN CORP·Filed 2001·Granted Nov 25, 2003·54 cites·27 claims
- 1190US5852195APyranone compounds useful to treat retroviral infectionsUPJOHN CO·Filed 1995·Granted Dec 22, 1998·48 cites·5 claims
- 1288US11795168B2Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2021·Granted Oct 24, 2023·1 cites·19 claims
- 1388US10959994B2Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrileFORMA THERAPEUTICS INC·Filed 2019·Granted Mar 30, 2021·4 cites·32 claims
- 1487US10703764B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Jul 7, 2020·2 cites·19 claims
- 1587US7253168B2Substituted 1-benzyl-4-substituted piperazine analoguesNEUROGEN CORP·Filed 2005·Granted Aug 7, 2007·13 cites·26 claims
- 1686US12053463B2Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrileFORMA THERAPEUTICS INC·Filed 2023·Granted Aug 6, 2024·0 cites·13 claims
- 1786US2025161292A1Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrileFORMA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1882US11566013B1Inhibiting mutant isocitrate dehydrogenase 1 (mIDH1)FORMA THERAPEUTICS INC·Filed 2020·Granted Jan 31, 2023·1 cites·20 claims
- 1977US12454532B2Inhibiting cyclic AMP-responsive element-binding protein (CREB) binding protein (CBP)FORMATHERAPEUTICS INC·Filed 2023·Granted Oct 28, 2025·0 cites·14 claims
- 2076US11723905B2Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrileFORMA THERAPEUTICS INC·Filed 2021·Granted Aug 15, 2023·0 cites·27 claims
- 2176US2025304583A1Inhibiting g cyclic amp-responsive element-binding protein (creb) binding protein (cbp)FORMA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2276US2023061891A1Tetrahydroquinoline compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2374US11084831B1Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2020·Granted Aug 10, 2021·0 cites·14 claims
- 2474US6169181B1Compounds useful to treat retroviral infectionsUPJOHN CO·Filed 1998·Granted Jan 2, 2001·33 cites·12 claims
- 2570US8119665B2Aryl imidazoles and related compounds as C5a receptor modulatorsLUKE GEORGE P·Filed 2007·Granted Feb 21, 2012·2 cites·13 claims
- 2667US6576766B1Signal transduction inhibitors, compositions containing themARIAD PHARMA INC·Filed 1998·Granted Jun 10, 2003·12 cites·73 claims
- 2766US6916827B2Substituted ring-fused imidazole derivative: GABAA receptors ligandsNEUROGEN CORP·Filed 2003·Granted Jul 12, 2005·2 cites·24 claims
- 2865US10793554B2Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanoneFORMA THERAPEUTICS INC·Filed 2019·Granted Oct 6, 2020·0 cites·23 claims
- 2965US2016257699A1Benzopiperazine compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3064US11267805B2Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanoneFORMA THERAPEUTICS INC·Filed 2020·Granted Mar 8, 2022·0 cites·21 claims
- 3163US2024131011A1Pyruvate kinase r (pkr) activating compositionsFORMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3259US2016257692A1Tetrahydroquinoline compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3357US7300945B2Benzimidazole and pyridylimidazole derivativesNEUROGEN CORP·Filed 2005·Granted Nov 27, 2007·0 cites·126 claims
- 3451US2010267698A1Benzimidazole and Pyridylimidazole DerivativesNEUROGEN CORP·Filed 2010·Application pending·0 cites
- 3548US12161634B2Pyruvate kinase R (PKR) activating compositionsNOVO NORDISK HEALTHCARE AG·Filed 2020·Granted Dec 10, 2024·0 cites·16 claims
- 3648US8466296B2Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7H-1,4-dioxino[2,3-e]indol-8-onesWANG ZHE-QING·Filed 2008·Granted Jun 18, 2013·0 cites·18 claims
- 3747US2021261528A1Salts of (s)-(5-cyclobutoxy-2-methyl-6-(1-(piperidin-4-yl)-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)(cyclopropyl)methanone and solid forms thereofFORMA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3843US2016256458A1Benzopiperazine compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3943US2016256448A1Tetrahydroquinoline compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when George P. Luke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →